组织陈列-产品详情

home > TISSUE ARRAYS > Liver > DLV805

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

80

CASES:

80

Core Diameter(mm):

2

Thickness(µm):

5

Row number:

8

Column number:

10

Tissue Array Type:

FFPE

Species:

Human

DLV805

$225.00

Add To Collect

Description: Liver tissue, hepatitis and cirrhosis tissue array, 80 cases/80 cores

Details: Liver tissue，hepatitis and cirrhosis tissue microarray, containing 30 cases adjacent normal or cancer adjacent liver tissue, 13 hepatitis, 37 cirrhosis, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

80 Cores 80 Cases Liver Matched or Unmatched Adjacent single core per case

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

NAT(*)
AT(*)
Inflammation(*)
Cirrhosis(*)
_ma

TISSUE ARRAYS
DLV805

	1	2	3	4	5	6	7	8	9	10
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma

DLV805

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Ki-67	CK18
A1	1	45	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	-	+,30%
A2	2	48	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	+	++,100%
A3	3	60	F	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	-	+,70%
A4	4	63	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	+	+,60%
A5	5	63	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	+,2%	++,100%
A6	6	62	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	+,3%	+++,100%
A7	7	52	F	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	-	++,90%
A8	8	58	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	+,2%	+,50%
A9	9	36	F	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	+,3%	+,70%
A10	10	47	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	-	++,100%
B1	11	38	M	Liver	Cancer adjacent liver tissue (mild inflammation)	*	*	*	AT	+,1%	+,30%
B2	12	41	M	Liver	Cancer adjacent liver tissue (mild inflammation)	*	*	*	AT	-	++,90%
B3	13	39	F	Liver	Cancer adjacent liver tissue (mild inflammation)	*	*	*	AT	*	*
B4	14	71	M	Liver	Cancer adjacent liver tissue (mild inflammation)	*	*	*	AT	*	+,20%
B5	15	49	M	Liver	Cancer adjacent liver tissue (degenerate)	*	*	*	AT	+,2%	+++,100%
B6	16	54	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	-	+,50%
B7	17	55	M	Liver	Cancer adjacent liver tissue (mild inflammation)	*	*	*	AT	-	++,90%
B8	18	58	F	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	-	+,70%
B9	19	54	F	Liver	Cancer adjacent liver tissue (mild inflammation)	*	*	*	AT	-	++,90%
B10	20	49	M	Liver	Cancer adjacent liver tissue (moderate inflammation)	*	*	*	AT	+,2%	++,100%
C1	21	63	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	-	++,80%
C2	22	38	M	Liver	Cancer adjacent liver tissue (mild inflammation)	*	*	*	AT	-	+,90%
C3	23	74	M	Liver	Cancer adjacent liver tissue (mild inflammation)	*	*	*	AT	-	+,70%
C4	24	41	M	Liver	Cancer adjacent liver tissue (mild inflammation)	*	*	*	AT	-	++,40%
C5	25	47	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	-	+,80%
C6	26	54	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	-	+,90%
C7	27	48	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	*	*
C8	28	53	M	Liver	Cancer adjacent liver tissue (mild inflammation)	*	*	*	AT	-	++,80%
C9	29	68	M	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	+,1%	+++,100%
C10	30	65	F	Liver	Adjacent normal liver tissue (mild inflammation)	*	*	*	NAT	-	+,60%
D1	31	51	F	Liver	Moderate chronic hepatitis	*	*	*	Inflammation	-	++,100%
D2	32	50	F	Liver	Mild inflammation	*	*	*	Inflammation	-	++,90%
D3	33	38	M	Liver	Mild inflammation	*	*	*	Inflammation	*	*
D4	34	51	M	Liver	Mild inflammation	*	*	*	Inflammation	+,15%	++,90%
D5	35	41	M	Liver	Mild inflammation	*	*	*	Inflammation	+,3%	++,90%
D6	36	49	M	Liver	Mild inflammation	*	*	*	Inflammation	-	++,80%
D7	37	46	M	Liver	Mild inflammation	*	*	*	Inflammation	*	*
D8	38	62	F	Liver	Mild inflammation	*	*	*	Inflammation	-	++,90%
D9	39	52	F	Liver	Mild inflammation	*	*	*	Inflammation	-	+,60%
D10	40	65	F	Liver	Mild inflammation	*	*	*	Inflammation	+,1%	+,30%
E1	41	68	F	Liver	Mild inflammation	*	*	*	Inflammation	-	+,60%
E2	42	77	M	Liver	Moderate hepatitis	*	*	*	Inflammation	-	++,100%
E3	43	68	F	Liver	Moderate hepatitis	*	*	*	Inflammation	*	*
E4	44	60	F	Liver	Hepatitis with cirrhosis	*	*	*	Cirrhosis	-	++,90%
E5	45	38	M	Liver	Hepatitis with early cirrhosis	*	*	*	Cirrhosis	-	+++,100%
E6	46	56	M	Liver	Hepatitis with cirrhosis	*	*	*	Cirrhosis	-	+,70%
E7	47	66	M	Liver	Hepatitis with cirrhosis	*	*	*	Cirrhosis	+,2%	+++,100%
E8	48	57	M	Liver	Cirrhosis with moderate inflammation	*	*	*	Cirrhosis	-	++,50%
E9	49	54	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,90%
E10	50	45	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,80%
F1	51	69	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,90%
F2	52	57	F	Liver	Early cirrhosis	*	*	*	Cirrhosis	-	+,70%
F3	53	62	M	Liver	Cirrhosis	*	*	*	Cirrhosis	+,2%	++,90%
F4	54	51	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	*
F5	55	53	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	+,70%
F6	56	60	M	Liver	Cirrhosis with moderate inflammation	*	*	*	Cirrhosis	+,2%	+++,100%
F7	57	45	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	+,30%
F8	58	37	M	Liver	Cirrhosis	*	*	*	Cirrhosis	+,1%	++,70%
F9	59	46	M	Liver	Cirrhosis with cholestasis	*	*	*	Cirrhosis	-	++,100%
F10	60	48	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	+,70%
G1	61	58	F	Liver	Cirrhosis (hepatocellular carcinoma)	*	*	*	Cirrhosis	-	+,40%
G2	62	24	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,90%
G3	63	69	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	+,50%
G4	64	45	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,60%
G5	65	58	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,80%
G6	66	62	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,80%
G7	67	53	F	Liver	Cirrhosis	*	*	*	Cirrhosis	-	+,20%
G8	68	37	M	Liver	Cirrhosis	*	*	*	Cirrhosis	+,2%	++,100%
G9	69	62	M	Liver	Cirrhosis	*	*	*	Cirrhosis	+,1%	+,20%
G10	70	53	M	Liver	Cirrhosis with degeneration	*	*	*	Cirrhosis	-	+,25%
H1	71	59	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,80%
H2	72	56	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	+,80%
H3	73	51	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	+,60%
H4	74	65	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	+,80%
H5	75	55	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,90%
H6	76	52	F	Liver	Cirrhosis	*	*	*	Cirrhosis	+,1%	+,30%
H7	77	40	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,90%
H8	78	36	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	+,90%
H9	79	72	F	Liver	Cirrhosis with degeneration	*	*	*	Cirrhosis	-	++,100%
H10	80	34	M	Liver	Cirrhosis	*	*	*	Cirrhosis	-	++,100%
_marker_

Find overlapping cases with this tissue array:

DLV805

File Format: .xlsx

Release Date: 2025-01-17 15:53:11
Download

	1	2	3	4	5	6	7	8	9	10
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma

	1	2	3	4	5	6	7	8	9	10
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma

	1	2	3	4	5	6	7	8	9	10
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma